Balyasny Asset Management LLC Metlife Inc Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Metlife Inc stock. As of the latest transaction made, Balyasny Asset Management LLC holds 76,500 shares of MET stock, worth $6.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

76,500

Previous 63,347 20.76%

Holding current value

$6.32 Million

Previous $4.45 Million 41.9%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$67.96 - $82.48 $131 Million - $159 Million	1,924,209 Added 3037.57%	1,987,556 $164 Million
Q2 2024 Aug 14, 2024	SELL	$68.55 - $74.22 $73.7 Million - $79.8 Million	-1,075,074 Reduced 94.44%	63,347 $4.45 Million
Q1 2024 May 13, 2024	BUY	$65.35 - $74.11 $67.7 Million - $76.8 Million	1,035,802 Added 1009.37%	1,138,421 $84.4 Million
Q4 2023 Feb 14, 2024	SELL	$58.29 - $66.9 $109,760 - $125,972	-1,883 Reduced 1.8%	102,619 $6.79 Million
Q3 2023 Nov 14, 2023	SELL	$56.71 - $66.36 $8.28 Million - $9.69 Million	-146,078 Reduced 58.3%	104,502 $6.57 Million
Q2 2023 Aug 14, 2023	SELL	$49.12 - $61.81 $4.6 Million - $5.78 Million	-93,562 Reduced 27.19%	250,580 $14.2 Million
Q1 2023 May 15, 2023	BUY	$54.3 - $73.58 $18.7 Million - $25.3 Million	344,142 New	344,142 $19.9 Million
Q3 2022 Nov 14, 2022	SELL	$22.01 - $68.52 $1.2 Million - $3.74 Million	-54,594 Reduced 56.55%	41,941 $2.55 Million
Q2 2022 Aug 15, 2022	BUY	$60.87 - $72.44 $4.02 Million - $4.79 Million	66,093 Added 217.11%	96,535 $6.06 Million
Q1 2022 May 16, 2022	SELL	$61.96 - $71.63 $918,061 - $1.06 Million	-14,817 Reduced 32.74%	30,442 $2.14 Million
Q4 2021 Feb 14, 2022	BUY	$57.11 - $66.6 $2.58 Million - $3.01 Million	45,259 New	45,259 $2.83 Million
Q1 2021 May 17, 2021	SELL	$46.08 - $61.76 $25.3 Million - $33.9 Million	-548,142 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$36.6 - $48.67 $6.58 Million - $8.75 Million	179,711 Added 48.78%	548,142 $25.7 Million
Q3 2020 Nov 16, 2020	BUY	$35.39 - $40.57 $13 Million - $14.9 Million	368,431 New	368,431 $13.7 Million
Q1 2020 May 15, 2020	SELL	$23.53 - $52.61 $33.5 Million - $74.8 Million	-1,422,156 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$43.83 - $51.36 $47.8 Million - $56 Million	-1,089,718 Reduced 43.38%	1,422,156 $72.5 Million
Q3 2019 Nov 14, 2019	BUY	$43.71 - $50.92 $109 Million - $127 Million	2,489,174 Added 10965.52%	2,511,874 $118 Million
Q2 2019 Aug 14, 2019	SELL	$43.93 - $49.67 $2.48 Million - $2.8 Million	-56,459 Reduced 71.32%	22,700 $1.13 Million
Q1 2019 May 15, 2019	BUY	$40.87 - $45.72 $3.24 Million - $3.62 Million	79,159 New	79,159 $3.37 Million
Q2 2018 Aug 14, 2018	SELL	$43.6 - $48.46 $2.43 Million - $2.7 Million	-55,739 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$44.08 - $54.77 $13.7 Million - $17.1 Million	-311,754 Reduced 84.83%	55,739 $2.56 Million
Q4 2017 Feb 14, 2018	SELL	$50.56 - $55.73 $13.6 Million - $15 Million	-268,439 Reduced 42.21%	367,493 $18.6 Million
Q3 2017 Nov 14, 2017	BUY	$46.68 - $51.95 $29.7 Million - $33 Million	635,932	635,932 $33 Million

Others Institutions Holding MET

# of Institutions

1,470

Shares Held

492M

Call Options Held

5.71M

Put Options Held

8.65M

View Full List

About METLIFE INC

Ticker MET
Exchange NYSE
Sector Financial Services
Industry Insurance—Life
Shares Outstandng 797,614,016
Market Cap $65.9B
Description
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disabilit...

More about MET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Metlife Inc Transaction History